James Schutz served as our vice president of corporate development and general counsel since August 2003, as a director since May 2004 and corporate secretary since June 2006. He was appointed CEO in February 2013. Mr. Schutz was formerly the general counsel of Jomed, Inc. until 2003 when he orchestrated the sale of Jomed to Abbott Laboratories (NYSE: ABT) and Volcano Therapeutics (NASDAQ: VOLC, now part of Royal Philips, NYSE PHG). Mr. Schutz received a B.A. in economics from the University of California, San Diego and a J.D. from the University of San Francisco School of Law.